共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | NIRAVAM |
| 申请号 | 021726 | 产品号 | 001 |
| 活性成分 | ALPRAZOLAM | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, ORALLY DISINTEGRATING;ORAL | 规格 | 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2005/01/19 | 申请机构 | UCB INC
|
| 2 | 药品名称 | NIRAVAM |
| 申请号 | 021726 | 产品号 | 002 |
| 活性成分 | ALPRAZOLAM | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, ORALLY DISINTEGRATING;ORAL | 规格 | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2005/01/19 | 申请机构 | UCB INC
|
| 3 | 药品名称 | NIRAVAM |
| 申请号 | 021726 | 产品号 | 003 |
| 活性成分 | ALPRAZOLAM | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, ORALLY DISINTEGRATING;ORAL | 规格 | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2005/01/19 | 申请机构 | UCB INC
|
| 4 | 药品名称 | NIRAVAM |
| 申请号 | 021726 | 产品号 | 004 |
| 活性成分 | ALPRAZOLAM | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET, ORALLY DISINTEGRATING;ORAL | 规格 | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2005/01/19 | 申请机构 | UCB INC
|